Stock Comparison
MDGL vs REGN
Madrigal Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$11.82B
$66.35B
P/E (TTM)
—
15.5
Forward P/E
666.7
14.1
Price/Sales
10.4
4.5
Price/Book
21.8
2.1
EV/EBITDA
-8.3
10.5
Dividend Yield
—
0.58%
Profitability
Net Margin
-27.30%
29.60%
Operating Margin
-29.80%
20.70%
Return on Equity
-49.30%
14.50%
Return on Assets
-17.60%
6.13%
Growth (YoY)
Revenue Growth
126.80%
19.00%
Earnings Growth
0.00%
-7.20%
Price & Risk
Beta
-1.1
0.2
52-Week High
$615.00
$818.90
52-Week Low
$284.02
$516.07
Analyst Target
$678.71
$833.31
Compare MDGL and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.